Living With SADS Webinars

Presented by: Andrew Landstrom, MD, PhD, Duke University School of Medicine

Have you ever wondered why some clinical trials succeed at bringing a new therapy to market and others don’t? Have you wondered why clinical trials take so long before a therapy is on the market? Do you have your own questions about clinical trials that you would like answered?

Join us to learn more and have YOUR questions answered.

Presented by: Whit Tingley, MD, Chief Medical Officer, Tenaya Therapeutics

During this webinar, Dr. Whit Tingley, of Tenaya Therapeutics, will share updates on Tenaya’s MyPEAK^TM-1 clinical trial for HCM due to a MYBPC3 mutation and their RIDGE^TM-1 trial for ARVC due to a PKP2 mutation. Dr. Tingley will explain how TN-201 and TN-401 are intended to work and will bring attendees up to date on recent announcements on the status of each trial. Q&A will follow his presentation.